ERBB2 and neoplasm: However, we also observed that the PDxBr model was able to effectively risk stratify patients with Her2 +ve and triple-negative disease by identifying 50 of the combined 70 events (70%), relying only on age, tumor size, stage, lymph node status and their H&E AI-grade phenotype.